비침습 유방암의 양·한방 협진 표준임상경로 모형 개발
Development of Clinical Pathway Model in Integrative Korean Medicine: Treatment of Non-invasive Breast Cancer
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objectives : The aim of this study was to develop a clinical pathway (CP) model for the integrative treatment of non-invasive breast cancer, with western medicine and Korean traditional medicine. Methods : The checklist model was composed in four types according to the target patients: DCIS inpatients, DCIS outpatients, LCIS inpatients, LCIS outpatients. The vertical axis of the pathway consists of 11 categories of actions applied to the patient. The horizontal axis was in accordance with the flow of time, comprising three periods during inpatient care and seven periods during outpatient care. In addition, CP was also composed in flow chart form. The pathway model was developed through a literature review of clinical practice guidelines, conference publications, papers, books, and websites. Results : The integrative CP model for non-invasive breast cancer was developed. Conclusions : The goal of the CP suggested in this study was to improve non-invasive breast cancer patients’ quality of life and to supplement conventional treatment, by alleviating the side effects. The model developed through this study could serve as the basis when developing CPs in a real-world integrative medical environment. This could lead to a reduction in cost and time for CP development, thus bringing about efficiency in the clinical setting.
Abstract
Objectives : The aim of this study was to develop a clinical pathway (CP) model for the integrative treatment of non-invasive breast cancer, with western medicine and Korean traditional medicine. Methods : The checklist model was composed in four types according to the target patients: DCIS inpatients, DCIS outpatients, LCIS inpatients, LCIS outpatients. The vertical axis of the pathway consists of 11 categories of actions applied to the patient. The horizontal axis was in accordance with the flow of time, comprising three periods during inpatient care and seven periods during outpatient care. In addition, CP was also composed in flow chart form. The pathway model was developed through a literature review of clinical practice guidelines, conference publications, papers, books, and websites. Results : The integrative CP model for non-invasive breast cancer was developed. Conclusions : The goal of the CP suggested in this study was to improve non-invasive breast cancer patients’ quality of life and to supplement conventional treatment, by alleviating the side effects. The model developed through this study could serve as the basis when developing CPs in a real-world integrative medical environment. This could lead to a reduction in cost and time for CP development, thus bringing about efficiency in the clinical setting.
참고문헌 (39)
- Badve SS, "Ductal carcinoma in situ of breast : update 2019", Pathology, 51(6), pp.563~569 (2019)
- Wong SM, "Breast cancer prevention strategies in lobular carcinoma in situ : A decision analysis", Cancer, 123(14), pp.2609~2617 (2017)
- "2020 Breast Cancer Facts & Figures" (2020)[URL]
- "Breast Cancer Clinical Practice Guideline of Korean Medicine" (2021)[URL]
- 박종민, "암 환자 22예에 대한 한방병원 내원동기 및 한방치료 만족도 조사", 동의신경정신과학회지, 26(1), pp.23~38 (2015), 대한한방신경정신과학회
- 이윤재, "유방암 환자 대상 침치료 무작위비교임상연구 고찰", 대한한방부인과학회지, 29(1), pp.78~91 (2016), 대한한방부인과학회[DOI]
- Lawal AK, "What is a clinical pathway? Refinement of an operational definition to identify clinical pathway studies for a Cochrane systematic review", BMC Med, 14, pp.35~ (2016)
- "2019 The 9th Korean Clinical Practice Guideline for Breast Cancer" (2019)[URL]
- Jabbour M, "Defining barriers and enablers for clinical pathway implementation in complex clinical settings", Implement Sci, 13(1), pp.139~ (2018)
- "NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Breast Cancer Ver 2.2022" (2021)[URL]
- "NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Survivorship Ver 3.2021" (2021)[URL]
- "Performance and Practice Guidelines for Breast-Conserving Surgery/Partial Mastectomy" (2015)[URL]
- "Performance and Practice Guidelines for Mastectomy" (2015)[URL]
- "Practice Guidelines for Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration: Application to Healthy Patients Undergoing Elective Procedures:An Updated Report by the American Society of Anesthesiologists Task Force on Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration", Anesthesiology, 126(3), pp.376~393 (2017)
- Chen J, "Randomized clinical trial of Chinese herbal medications to reduce wound complications after mastectomy for breast carcinoma", Br J Surg, 97(12), pp.1798~1804 (2010)
- 이강욱, "유방암 치료에 대한 한의 임상 가이드라인 개발을 위한 기초연구", 대한한방부인과학회지, 29(2), pp.47~65 (2016), 대한한방부인과학회[DOI]
- Lyman GH, "Integrative Therapies During and After Breast Cancer Treatment : ASCO Endorsement of the SIO Clinical Practice Guideline", J Clin Oncol, 36(25), pp.2647~2655 (2018)
- 오경민, "불면환자의 수면의 질 척도, 우울척도, 한방진단시스템과의 연관성 연구(1)", 동의신경정신과학회지, 20(3), pp.89~119 (2009), 대한한방신경정신과학회
- 김용우, "림프마사지와 저항운동이 유방암환자의 수술방법에 따른 상지기능 변화", 한국체육학회지, 49(1), pp.491~497 (2010), 한국체육학회
- Yeun EJ, "Medical-Surgical Nursing I", pp.316~382 (2019), Soomoonsa
- Yeun EJ, "Medical-Surgical Nursing II", pp.1519~1524 (2019), Soomoonsa
- The Society of Korean Medicine Obstetrics and Gynecology, "Korean Medicine Obstetrics &Gynecology II", pp.458~467 (2021), Eui-Seong-Dang Publishing
- Korean Association of Traditional Oncology, "Integrative Oncology of Korean Medicine", pp.335~353 (2013), Koonja Publishing
- Johnson BL, "Handbook of Oncology Nursing", pp.32~60 (2000), Hyunmoon Publishing
- Abrams D, "Integrative Oncology", pp.85~124 (2009), E Public
- "Breast Cancer" (2019)[URL]
- "Follow-up Care After Breast Cancer Treatment" (2022)[URL]
- "Tests and visits before surgery" (2020)[URL]
- "Postdischarge precautions for breast surgery patients" (2017)[URL]
- 김정현, "요추 추간판 탈출증의 4종 한의표준임상경로(CP) 개발 및 시범적용 연구", 대한한의학회지, 42(3), pp.1~8 (2021), 대한한의학회
- Jaggers LD, "Differentiation of critical pathways from other health care management tools", Am J Health Syst Pharm, 53(3), pp.311~313 (1996)
- 김미경, "중풍 입원 환자 관리를 위한 임상경로 개발", 대한한의학회지, 42(2), pp.62~71 (2021), 대한한의학회
- 오가은, "양·한방 협진 의료서비스 최적화를 위한 Clinical Pathway 도입과 진료패턴 분석", 대한한의진단학회지, 16(2), pp.23~32 (2012), 대한한의진단학회
- 김병준, "요추 수술 후 급성기 통증 환자에 대한 통합의학 표준임상경로 임상시험 프로토콜", 한방재활의학과학회지, 27(4), pp.111~119 (2017), 한방재활의학과학회
- 홍미나, "‘항암화학요법을 받은 폐암 환자의 예비 통합의학 임상경로’ 개발 및 타당도 평가", 대한한방내과학회지, 38(6), pp.917~929 (2017), 대한한방내과학회
- 엄윤지, "화병 표준진료지침 적용효과에 대한 Pilot 분석", 동의신경정신과학회지, 32(4), pp.337~343 (2021), 대한한방신경정신과학회[DOI]
- 최수지, "월경통 한의표준임상경로 적용 가능성 및 유효성 평가 연구 프로토콜", 대한한방부인과학회지, 35(1), pp.75~90 (2022), 대한한방부인과학회[DOI]
- "number of new patients, relative frequency, crude incidence rate, agestandardized incidence rate: by 24 cancer types and gender" (2022)[URL]
- Ganz PA, "Quality-of-life issues in patients with ductal carcinoma in situ", J Natl Cancer Inst Monogr, 2010(41), pp.218~222 (2010)